Advertisement
Screener

89bio, Inc. Patents: Active

89bio, Inc. Active Patents

4 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-11-08: Application 18504561; Invention LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES; Applicant 89bio, Inc.; Status Patented Case.
  • 2023-06-23: Application 18340421; Invention COMPOSITIONS AND METHODS OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA; Applicant 89bio, Inc.; Status Patented Case.
  • 2023-02-06: Application 18165081; Invention LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES; Applicant 89BIO, INC.; Status Patented Case.
  • 2022-03-10: Application 17692024; Invention LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES; Applicant 89Bio, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-11-0818504561LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES89bio, Inc.Patented Case2025-07-0812350314US20240307492A1
Boris Schwartsburd
Shaji Joseph
Israel
United States
MIKNIS, ZACHARY J
2023-06-2318340421COMPOSITIONS AND METHODS OF TREATMENT FOR SEVERE HYPERTRIGLYCERIDEMIA89bio, Inc.Patented Case2024-07-1612036284US20230414768A1
Hank Mansbach
Leo Tseng
United States
United States
CHANDRA, GYAN
2023-02-0618165081LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES89BIO, INC.Patented Case2023-12-2611850275US20230338471A1
Boris SCHWARTSBURD
Shaji JOSEPH
Israel
United States
MIKNIS, ZACHARY J
2022-03-1017692024LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES89Bio, Inc.Patented Case2023-03-0711596669US20220296678A1
Boris Schwartsburd
Shaji Joseph
Israel
United States
MIKNIS, ZACHARY J